WellGen, Inc. Completes Human Study Paving Way for Nutrigenomics to Play Important Role in Mainstream Product Development

NEW BRUNSWICK, N.J., April 10 /PRNewswire/ -- WellGen, Inc. today announced that it has completed a pivotal study demonstrating that its nutrigenomics technology platform can successfully predict biological activity of natural products in humans. WellGen is a biotechnology company that uses nutrigenomics to discover and develop proprietary functional food ingredients.
MORE ON THIS TOPIC